Last reviewed · How we verify

NCT05114512: RAPTOR

Rural Access to Physical Therapy for Osteoarthritis Rehabilitation - Pilot

Completed NA Last updated 4 October 2024
What this trial tests

NA trial testing RAPTOR protocol: hybrid in-person + telehealth physical therapy services in Osteoarthritis, Knee in 27 participants. Completed in 30 September 2024.

Timeline
20 December 2021
Primary endpoint
30 September 2024
30 September 2024

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment27
Start date20 December 2021
Primary completion30 September 2024
Estimated completion30 September 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

40 and older, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pilot study involving a hybrid in-person + telerehabilitation intervention for rural adults with knee osteoarthritis. The primary purpose is to demonstrate feasibility and safety of the RAPTOR program, and the secondary purpose is to estimate clinical effectiveness of the RAPTOR program on participants' pain, function, and quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05114512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing